Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Dividend Announcement
• Baxter International announced a quarterly dividend of $0.29 per ordinary share which will be made payable on 2024-10-01. Ex dividend date: 2024-08-30
• Baxter International annual dividend for 2024 was $0.87
• Baxter International annual dividend for 2023 was $1.16
• Baxter International's trailing twelve-month (TTM) dividend yield is 3.63%
• Baxter International's payout ratio for the trailing twelve months (TTM) is 546.30%
• Baxter International's dividend growth over the last five years (2018-2023) was 9.71% year
• Baxter International's dividend growth over the last ten years (2013-2023) was -4.91% year
Baxter International Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-30 | $0.29 | quarterly | 2024-10-01 |
2024-05-31 | $0.29 | quarterly | 2024-07-01 |
2024-02-29 | $0.29 | quarterly | 2024-04-01 |
2023-11-30 | $0.29 | quarterly | 2024-01-02 |
2023-08-31 | $0.29 | quarterly | 2023-10-02 |
2023-06-01 | $0.29 | quarterly | 2023-07-03 |
2023-02-23 | $0.29 | quarterly | 2023-04-03 |
2022-12-01 | $0.29 | quarterly | 2023-01-03 |
2022-09-01 | $0.29 | quarterly | 2022-10-03 |
2022-06-02 | $0.29 | quarterly | 2022-07-01 |
2022-02-24 | $0.28 | quarterly | 2022-04-01 |
2021-12-02 | $0.28 | quarterly | 2022-01-03 |
2021-09-02 | $0.28 | quarterly | 2021-10-01 |
2021-06-03 | $0.28 | quarterly | 2021-07-01 |
2021-02-25 | $0.24 | quarterly | 2021-04-01 |
2020-12-03 | $0.24 | quarterly | 2021-01-04 |
2020-08-28 | $0.24 | quarterly | 2020-10-01 |
2020-06-04 | $0.24 | quarterly | 2020-07-01 |
2020-02-27 | $0.22 | quarterly | 2020-04-01 |
2019-12-05 | $0.22 | quarterly | 2020-01-02 |
2019-08-29 | $0.22 | quarterly | 2019-10-01 |
2019-06-06 | $0.22 | quarterly | 2019-07-01 |
2019-02-28 | $0.19 | quarterly | 2019-04-01 |
2018-11-30 | $0.19 | quarterly | 2019-01-02 |
2018-08-30 | $0.19 | quarterly | 2018-10-01 |
2018-05-31 | $0.19 | quarterly | 2018-07-02 |
2018-03-01 | $0.16 | quarterly | 2018-04-02 |
2017-11-30 | $0.16 | quarterly | 2018-01-02 |
2017-08-30 | $0.16 | quarterly | 2017-10-02 |
2017-05-31 | $0.16 | quarterly | 2017-07-03 |
2017-03-01 | $0.13 | quarterly | 2017-04-03 |
2016-11-30 | $0.13 | quarterly | 2017-01-03 |
2016-08-31 | $0.13 | quarterly | 2016-10-03 |
2016-06-01 | $0.13 | quarterly | 2016-07-01 |
2016-03-02 | $0.12 | quarterly | 2016-04-01 |
2015-12-02 | $0.12 | quarterly | 2016-01-04 |
2015-09-02 | $0.12 | quarterly | 2015-10-01 |
2015-05-28 | $0.52 | quarterly | 2015-07-01 |
2015-03-09 | $0.52 | quarterly | 2015-04-01 |
2014-12-03 | $0.52 | quarterly | 2015-01-02 |
2014-09-03 | $0.52 | quarterly | 2014-10-01 |
2014-06-04 | $0.52 | quarterly | 2014-07-01 |
2014-03-05 | $0.49 | quarterly | 2014-04-01 |
2013-12-04 | $0.49 | quarterly | 2014-01-03 |
2013-09-04 | $0.49 | quarterly | 2013-10-01 |
2013-06-05 | $0.49 | quarterly | 2013-07-01 |
2013-03-06 | $0.45 | quarterly | 2013-04-01 |
Baxter International Dividend per year
Baxter International Dividend growth
Baxter International Dividend Yield
Baxter International current trailing twelve-month (TTM) dividend yield is 3.63%. Interested in purchasing Baxter International stock? Use our calculator to estimate your expected dividend yield:
Baxter International Financial Ratios
Baxter International Dividend FAQ
Other factors to consider when evaluating Baxter International as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Baxter International stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Baxter International's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Baxter International publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Baxter International distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Baxter International are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Baxter International sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Baxter International distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Baxter International declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Baxter International's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Baxter International's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.